Novo Nordisk A/S ADR (NY: NVO )
90.94 -0.58 (-0.63%) Official Closing Price Updated: 7:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Press Releases about Novo Nordisk A/S ADR
MarketBeat Week in Review – 8/7 - 8/11
August 12, 2023
The latest inflation readings failed to provide clarity for investors as stocks had a turbulent week and the MarketBeat team was covering the top stories
Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results
August 09, 2023
Novo Nordisk's stock surged 16% on preliminary results of clinical trials showing its weight-loss drug Wegovy reduces risk of cardiovascular disease by 20%.
Topics Artificial Intelligence
Exposures Artificial Intelligence
EXL Announces Appointment of Andreas Fibig to Board of Directors
January 12, 2023
Obesity And Back Pain: BioRestorative Therapies Inc. Is Working To Address 2 Common Ailments That Plague Americans with a Major Near Term Data Catalyst
September 01, 2022
In 2016, Americans spent roughly $380 billion on lower back and neck pain. In the same year, medical costs for adult obesity in the United States were $260.6 billion. That’s why BioRestorative...
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
August 18, 2022
Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds...
Exposures Product Safety
Palm Beach, FL – July 26, 2022 – FinancialNewsMedia.com News Commentary – As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, concern it could...
Palm Beach, FL – May 31, 2022 – FinancialNewsMedia.com News Commentary – Diabetes is a chronic health condition that occurs when your body’s blood glucose, also called blood sugar, is too high. Blood...